CLDX - Why Celldex Therapeutics (CLDX) Stock Is Getting Hammered | Benzinga
Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares are trading lower after the company announced a proposed public offering of 7.425 million shares at $27 per share.
What Else?
The offering entails an option for underwriters to purchase an additional ...
CLDX) Stock Is Getting Hammered>Full story available on Benzinga.com